Skip to search formSkip to main contentSkip to account menu

givinostat

Known as: Gavinostat 
An orally bioavailable hydroxymate inhibitor of histone deacetylase (HDAC) with potential anti-inflammatory, anti-angiogenic, and antineoplastic… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Carbamates
ITF 2357NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The suppressive effect of the epigenetic drug, Givinostat (ITF2357), on peripheral blood leukocytes from uveitis patients
2016
2016
A physically and chemically stable oral suspension of GIVINOSTAT
Physiologically and chemically stable oral liquid preparations of givinostat (diethyl- [6- (4-hydroxycarbamoyl… 
2016
2016
Suspensions orales de givinostat physiquement et chimiquement stables
L'invention concerne des formulations orales liquides, physiquement et chimiquement stables, de Givinostat (chlorure de diethyl… 
2015
2015
Effect of HDACi Givinostat in Treating Experimental Ocular Autoimmunity
2014
2014
CARATTERIZZAZIONE DELL'ATTIVITA' ANTITUMORALE DELL'INIBITORE DEGLI HDAC ITF2357 (GIVINOSTAT®) IN MODELLI PRECLINICI DI LINFOMA NON-HODGKIN A CELLULE B C-MYC POSITIVI
2012
2012
Murine Makrophagen zeigen einen M2-Phänotyp und ein verändertes IL-6-Signaling nach Behandlung mit dem HDAC-Inhibitor Givinostat (ITF2357)